Intensity Therapeutics, Inc.'s total assets for Q3 2025 were $9.59M, an increase of 115.73% from the previous quarter. INTS total liabilities were $2.36M for the fiscal quarter, a 4.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.